{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:51:05Z","timestamp":1758127865867},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":6541,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1990,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Five patients with PRL\u2010secreting macroadenoma and nine patients with PRL\u2010secreting microadenoma or idiopathic hyperprolactinaemia were treated with monthly administrations of long\u2010acting bromocriptine suitable for repeatable injections (Parlodel LAR) for 1\u201312 cycles of treatment. A significant shrinkage of tumour mass and the recovery of visual field defects were observed in patients with macroprolactinoma. Plasma PRL levels decreased to 16.8 and 18.1% of pretreatment values, in macroprolactinoma and idiopathic or microadenoma\u2010tous hyperprolactinaemic subjects, respectively, during the first cycle of treatment, reaching the normal range in three patients of each group. During the following cycles of treatment, two patients with macroprolactinoma and one patient with idiopathic or microadenomatous hyperprolactinaemia became normoprolactinaemic. Adverse reactions generally did not last beyond the first days of administration and decreased with the progression of the treatment. In conclusion, its effectiveness and the fact that it is well tolerated, may suggest that this form of bromocriptine may be used as a first therapeutic approach for patients with PRL\u2010secreting adenomas, particularly when shrinkage of a macroadenoma is urgently required.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1990.tb00479.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:58:43Z","timestamp":1205755123000},"page":"161-170","source":"Crossref","is-referenced-by-count":25,"title":["RAPID AND LONG\u2010LASTING SUPPRESSION OF PROLACTIN SECRETION AND SHRINKAGE OF PROLACTINOMAS AFTER INJECTION OF LONG\u2010ACTING REPEATABLE FORM OF BROMOCRIPTINE (PARLODEL LAR)*"],"prefix":"10.1111","volume":"33","author":[{"given":"GENNARO","family":"SCHETTINI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GAETANO","family":"LOMBARDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BARTOLOMEO","family":"MEROLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNAMARIA","family":"COLAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAOLO","family":"MILETTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ENZO","family":"CARUSO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IOANA","family":"LANCRANJAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"239","volume-title":"Lysuride and Other Dopamine Agonists","author":"Besser G. M.","year":"1983"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-4-737"},{"key":"e_1_2_1_4_1","first-page":"79","article-title":"Effects of a new long\u2010acting form of bromocriptine on tumorous hyperprolactinemia","volume":"109","author":"Ciccarelli E.","year":"1987","journal-title":"Journal Endocrinological Investigation"},{"key":"e_1_2_1_5_1","first-page":"614A","article-title":"Possible antitumor effect of 2\u2010bromoergocryptine (CB 154\u2010Sandoz) in two patients with large prolactin\u2010secreting adenomas","volume":"23","author":"Corenblum B.","year":"1975","journal-title":"Clinical Research"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb00767.x"},{"key":"e_1_2_1_7_1","first-page":"569","volume-title":"Brain and Female Reproductive Function","author":"Lancranjan I.","year":"1987"},{"key":"e_1_2_1_8_1","unstructured":"Lancranjan I. Rolland R.andL'Hermite M.(1987a)Inhibition of lactation with depot\u2010bromocriptine.Annals of the New York Academy of Science 115\u2013130."},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92976-3"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-4-698"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-1-266"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350096"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0015-0282(16)43335-2","article-title":"Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction","volume":"29","author":"Vaidya R. A.","year":"1978","journal-title":"Fertility and Sterility"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1990.tb00479.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1990.tb00479.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T11:23:04Z","timestamp":1697973784000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1990.tb00479.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,8]]}},"alternative-id":["10.1111\/j.1365-2265.1990.tb00479.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb00479.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,8]]}}}